1 completed, 1 terminated, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Upper Extremity Deep Vein Thrombosis: new trials by email Literature Review of Upper Extremity Deep Vein Thrombosis trials Research Report on Upper Extremity Deep Vein Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter 4% sodium citrate, heparin group - Central Venous Catheter Thrombosis, Renal Dialysis | Phase 2 / Phase 3 | Unknown | Chang Gung Memorial Hospital | 120 | 2022-07-20 | 2022-07-25 |
| THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) Rivaroxaban 10 MG, Placebo - Sickle Cell Disease, Central Venous Catheter Thrombosis | Phase 3 | Terminated | University Health Network, Toronto | 4 | 2022-06-07 | 2025-03-19 |
| Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines Rivaroxaban 10 MG - Upper Extremity Deep Vein Thrombosis, Central Venous Catheter Thrombosis | Phase 3 | Completed | Ottawa Hospital Research Institute | 105 | 2019-03-15 | 2024-07-05 |
Anemia, Sickle Cell (1) · Neoplasms (1) · Venous Thromboembolism (1)
Cardiovascular Diseases (3) · Embolism and Thrombosis (3) · Thrombosis (3) · Vascular Diseases (3) · Venous Thrombosis (3) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemoglobinopathies (1) · Thromboembolism (1)
Rivaroxaban (2) · Sodium Citrate (1)
Chang Gung Memorial Hospital (1) · Ottawa Hospital Research Institute (1) · University Health Network, Toronto (1)
Canada (2) · Taiwan (1)